Andrew Atkinson, PhD

Washington University School of Medicine

Disclosure(s): No financial relationships to disclose

Poster(s):

• (P-5) Readmission Outcomes of Vancomycin Compared to Daptomycin for Outpatient Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Bloodstream Infections– Analysis of U.S. Claims-Based Data
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET

• (P-630) Seasonal Influenza Vaccination and Household Contact Susceptibility to Influenza and Symptomatic Infection Outcomes: a Case-Ascertained Household Transmission Study, United States, 2023-2024
  Monday, October 20, 2025

  12:15 PM - 1:30 PM US ET

• (P-1295) Use of Large Language Models Does Not Improve Model Performance for Antimicrobial Resistance Prediction in Community- and Hospital-Onset Gram Negative Sepsis
  Tuesday, October 21, 2025

  12:15 PM - 1:30 PM US ET

• (P-1528) Investigating Patient and Microbiological Factors to Unravel the Path to Septic Shock
  Wednesday, October 22, 2025

  12:15 PM - 1:30 PM US ET